Roivant Sciences Announces Change to its Board of Directors
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq:ROIV) today announced that its founder Vivek Ramaswamy has stepped down from the company’s board of directors to focus on his U.S. presidential campaign.
Related news for (ROIV)
- Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024
- Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
- Lokavant Hires Experienced Leaders to Accelerate Growth Trajectory
- Lokavant Emerges from Roivant Sciences with Multiple Industry Partnerships to Accelerate Impact on Clinical Research
- Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement